Skip to Main Content
Skip Nav Destination

The landscape of cancer therapeutics is rapidly evolving with the introduction of novel treatments, such as immunotherapy. DNA damage repair pathways have been implicated in the emergence of and prognostication of cancer. However, extensive study has led to the creation of a host of agents moderating the DNA damage response to optimise anticancer activity.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal